Clinical Trials Logo

Hyperglycemia clinical trials

View clinical trials related to Hyperglycemia.

Filter by:

NCT ID: NCT01621776 Completed - Type 1 Diabetes Clinical Trials

Effect of Apidra Compared to Humalog in Decreasing Post-Prandial Hyperglycemia

Start date: June 2011
Phase: N/A
Study type: Interventional

This study aims to compare the post-meal blood glucose values of two drugs in a "real-world‟ setting.

NCT ID: NCT01595919 Completed - Obesity Clinical Trials

A Comparison of Beverages Consumed Within a Meal to Satiation on Meal-time Food Intake and Post-meal Appetite and Glycemic Response in Healthy Young Adults

Start date: April 2011
Phase: N/A
Study type: Interventional

The objective of the current study is to determine the effects of an ad libitum intake of 1% milk, fruit juice, regular cola, diet cola and water, as part of a pizza meal, on meal food intake, appetite and postprandial blood glucose in healthy men and women. We hypothesize that 1% milk will reduce food intake and result in better post-meal glycemic response compared to the other beverages.

NCT ID: NCT01580150 Completed - Hyperglycemia Clinical Trials

Effects of Berries on Post-meal Blood Sugar

SOMA
Start date: November 2009
Phase: N/A
Study type: Interventional

The purpose of this study is to investigate whether berries are effective in lowering blood glucose and insulin responses to meals containing starch or sucrose.

NCT ID: NCT01548963 Completed - Clinical trials for Tight Glycemia Control

Perioperative Versus Postoperative Glycemia Control in Cardiac Surgery Patients

Start date: January 2007
Phase: N/A
Study type: Interventional

It is known that acute stress of organism often leads to hyperglycemia even in nondiabetic patients. It is also known that pathophysiological mechanisms: enhanced gluconeogenesis, impaired insulin secretion and decreased insulin sensitivity due to anti-insulin effect of stress hormones and proinflammatory cytokines, or changes of glucose excretion and renal tubular resorption. Many studies proved the negative effects of hyperglycemia to different tissues and organs, e.g. hearth (increasing size of myocardial necrosis, reducing coronary collateral blood flow, exaggerating ischemia-reperfusion injury, impairing ischemic preconditioning), vascular (increased risk of thrombosis, endothelial dysfunction, activation of systemic inflammation with destabilization of atherosclerotic plaques), kidneys and its association with infectious complications. The first Leuven study (published in 2001) demonstrated that hyperglycemia in critical care patients significantly increases risk of organ complication and total mortality. Although the importance of postoperative tight glycemia control is now widely accepted, glycemia stability during cardiac surgery is often neglected. It is known that postoperative hyperglycemia has negative effects, but it is not known what effect has its peroperative elevation. Goal of this study is to demonstrate, whether full perioperative intensive glycemia control can reduce the incidence of postoperative morbidity even more than postoperative glycemia control only.

NCT ID: NCT01545700 Completed - Clinical trials for Postoperative Complications

Effect of Low-Dose Dexamethasone on the Incidence of Hyperglycemia Following Surgery

Start date: September 2009
Phase: Phase 4
Study type: Interventional

The question of a possible hyperglycemic effect from single-dose dexamethasone is an important issue for clinicians managing patients in the intraoperative and postoperative periods. Recent evidence suggests that even moderate elevations in blood glucose levels may be associated with adverse events. The aim of this clinical investigation is to determine whether standard clinical doses of dexamethasone produce hyperglycemia in the perioperative period.

NCT ID: NCT01530685 Completed - Hyperglycemia Clinical Trials

Gycabiane and Glycemic Control of Prediabetic Subjects

Start date: October 27, 2011
Phase: N/A
Study type: Interventional

The purpose of this study is to examine the effects of supplementation Glycabiane, a dietary supplement, on glycemic control of overweight prediabetic subjects.

NCT ID: NCT01526044 Completed - Hypoglycaemia Clinical Trials

Continuous Glucose Monitoring by Subcutaneous Measurement Compared to Frequent Point of Care Measurement by Accu Chek in Critically Ill Patients

RESCUEII
Start date: December 2010
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the accuracy and reliability of the continuous glucose monitoring system the FreeStyle Navigator® (Abbott, Diabetes Care) in critically ill patients by comparing subcutaneous measuring with the current standard of arterial measuring by a point of care glucometer.

NCT ID: NCT01472640 Completed - Hyperglycemia Clinical Trials

The Effect of Liraglutide on Left Ventricular Function in Chronic Heart Failure Patients With and Without Type 2 Diabetes Mellitus

Start date: November 2011
Phase: N/A
Study type: Interventional

Type 2 diabetes (T2D) is a major risk factor of chronic heart failure (CHF). Glycemic control in patients with the combination of T2D and CHF is complicated and the currently available treatments have proven to be inadequate in clinical trials. Objectives To investigate the effect of Liraglutide compared to placebo on left ventricular ejection fraction (LVEF) in CHF patients with and without T2D. Multicenter, randomized, double blind study of 240 patients with documented systolic CHF (50% with T2DM) will be randomised. The effect of Liraglutide on left ventricular systolic and diastolic function will be evaluated by advanced echocardiography Primary outcome parameter is change in LVEF from visit 1 to week 24.

NCT ID: NCT01441518 Completed - Clinical trials for Gestational Diabetes Mellitus

Home Versus Hospital Care in Glucose Monitoring of Gestational Diabetes and Mild Gestational Hyperglycemia

Start date: May 2010
Phase: Phase 2
Study type: Interventional

Pregnancies complicated by diabetes and mild gestational hyperglycemia are associated with increased perinatal and maternal complications. The most serious maternal complication is the risk of developing type 2 diabetes after 10-12 years of the delivery. Perinatal complications include fetal macrosomia with consequent increased risk of obstetrical trauma and hypoxia/asphyxia, high rates of cesarean section, respiratory distress syndrome, and metabolic disorders at birth. Regardless of the diagnosis of diabetes and mild gestational hyperglycemia, the perinatal outcome is directly related to maternal metabolic control. For the tight control of blood glucose, pregnant women are treated as home care (outpatient) or hospital care. Objective: To evaluate the cost-effectiveness and safety of home versus hospital care of gestational diabetes and mild gestational hyperglycemia.

NCT ID: NCT01440842 Completed - Clinical trials for Stress Hyperglycaemia

Closed Loop Glucose Control in Intensive Care Unit

CLASSIC
Start date: May 2012
Phase: Phase 2
Study type: Interventional

The purpose of this study is to assess the efficacy, safety and feasibility of a computer-based control algorithm to control glucose levels in adults in intensive care unit, in comparison to standard care.